Literature DB >> 10113574

Economic evaluation in health care: is there a role for cost-benefit analysis?

M Johannesson1, B Jönsson.   

Abstract

This paper is devoted to the contingent valuation (CV) method and its possible area of application in health economics. With the CV method willingness to pay or willingness to accept is measured with survey methods. The CV method has been developed in environmental economics and is now the most commonly used method of measuring environmental benefits. The method has, however, seldom been used in economic evaluations of health care. The development of economic evaluation in the health care area is reviewed, and the existing methods (the human capital approach, cost-effectiveness analysis and cost-utility analysis) are compared with cost-benefit analysis using the CV method. It is shown that existing methods have several weak points, this makes the CV method an appealing alternative and/or complement to existing methods. From the empirical applications of the CV method in economic evaluations of health care it is evident that it is possible to achieve acceptable response rates. The methodological problems encountered when measuring willingness to pay with survey methods are shown to be similar to the problems encountered when measuring utility and quality of life in cost-utility analysis. Further studies with the CV method are necessary to further explore questions concerning the reliability and validity of the method.

Entities:  

Mesh:

Year:  1991        PMID: 10113574     DOI: 10.1016/0168-8510(91)90114-d

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  42 in total

1.  Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel.

Authors:  G Chodick; Y Lerman; T Peled; H Aloni; S Ashkenazi
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

3.  Willingness to pay for mammography: item development and testing among five ethnic groups.

Authors:  T H Wagner; T W Hu; G V Dueñas; R J Pasick
Journal:  Health Policy       Date:  2000-09       Impact factor: 2.980

4.  Willingness to pay. What's in a name?

Authors:  A Gafni
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 5.  Willingness to pay as a measure of health benefits.

Authors:  M V Bala; J A Mauskopf; L L Wood
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

6.  Cost effectiveness analysis in health care: contraindications.

Authors:  Cam Donaldson; Gillian Currie; Craig Mitton
Journal:  BMJ       Date:  2002-10-19

7.  Acceptability of willingness to pay techniques to consumers.

Authors:  Susan J Taylor; Carol L Armour
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

8.  Defining monetary values for quality of life improvements: an exploratory study.

Authors:  Jean Lachaine; Claudine Laurier; André-Pierre Contandriopoulos
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 9.  Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

Authors:  B J O'Brien; M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

10.  The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?

Authors:  M Johannesson
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.